Your gut lining is one cell thick. A single layer of enterocytes, sealed edge-to-edge by tight junction proteins, is the only barrier standing between the inside of your intestinal tube — which is, anatomically, the outside world — and your bloodstream. When that seal fails, large food proteins, bacterial fragments, and lipopolysaccharide endotoxin from gram-negative gut bacteria slip into the lamina propria, get sampled by Peyer's patch immune tissue, and trigger a systemic inflammatory cascade that the practitioner corpus traces to virtually every chronic disorder downstream: autoimmunity, brain fog, eczema, mood disorders, insulin resistance, neurodegeneration. Leaky gut is not a fringe diagnosis. It is the upstream lever.
The tight junction machinery
The cells that line your small intestine are held together by tight junction protein complexes — picture Lego blocks snapped edge-to-edge with no gaps. Zonulin is the protein that regulates how tightly those blocks hold. When zonulin is released — by gluten exposure, by dysbiotic bacteria, by certain lectins binding the gut wall — it tells the tight junctions to loosen. The space between cells widens. Antigens that should never have crossed the barrier now flood through.
The practitioner corpus is consistent on the trigger pathway. Lectins and certain food proteins bind receptors on the gut lining and prompt zonulin release. Zonulin pries open the tight junctions. Microbial fragments, undigested food proteins, and lipopolysaccharide cross the now-porous barrier into the lamina propria — the immune-rich layer immediately beneath the epithelium. Resident immune cells sample these foreign proteins and launch an inflammatory response. Cytokines flood the bloodstream. The cycle becomes self-reinforcing: inflammation slows gut motility, slower motility gives inflammatory cytokines more time to cross into circulation, circulation carries them past the blood-brain barrier, and you now have a leaky gut driving a leaky brain.
The LPS loop
Lipopolysaccharide — LPS — is the outer membrane component of gram-negative bacteria. In a sealed gut, LPS stays in the lumen and gets excreted. In a leaky gut, LPS crosses the epithelium, binds TLR4 receptors on immune cells, and triggers TNF-α and other pro-inflammatory cytokines. The vagus nerve, which threads through the gut and reports upward to the brainstem, responds to circulating TNF-α by altering its motor output. The gut-brain axis is not metaphorical — it is a measurable cytokine-vagus feedback loop.
Three-quarters of your immune system lives in the gut wall. When the barrier fails, that immune system is no longer running surveillance on a contained tube; it is running a war against systemic antigen leakage. This is why leaky gut shows up clinically as Hashimoto, eczema, IBD, anxiety, food sensitivities, joint pain, and brain fog — different downstream organs, same upstream barrier failure.
The dysbiosis layer
The mucosal barrier sits on top of the microbiome. A healthy microbiome produces short-chain fatty acids — butyrate especially — that feed enterocytes and reinforce tight junction integrity. A dysbiotic microbiome does the opposite: fermentation byproducts and bile acid metabolism shift colon pH, microbial diversity collapses, and the loss of barrier-supporting commensals leaves the epithelium underfed and the tight junctions weakened. The practitioner corpus is explicit: you cannot repair the gut lining without addressing the microbiome that feeds it, and you cannot stabilize the microbiome without repairing the lining that houses it. They go together.
The compound stack — Phase 1 reset
This is the upstream-lever intervention. Phase 1 of the Gut Repair Path stabilizes the epithelial barrier and quiets the inflammatory cascade. Specific doses arrive in Module 3 — this chapter establishes the mechanistic targets.
| Compound | Mechanistic target | Evidence Tier | Notes |
|---|---|---|---|
| BPC-157 | Enterocyte turnover, tight junction repair, angiogenesis at damaged gut wall | 🟢 Expert | The connective-tissue and gut-lining repair anchor. Doses detailed in Module 3. |
| KPV | Anti-inflammatory tripeptide; downregulates NF-κB and pro-inflammatory cytokines in gut tissue | 🟢 Expert | Oral route survives gut transit — unusual for peptides. |
| LL-37 | Antimicrobial peptide; targets gram-negative overgrowth driving LPS load | 🟣 Experimental | Used when SIBO or dysbiotic overgrowth is the upstream driver. |
| Thymosin Alpha-1 | Regulatory T-cell expansion; quiets the over-reactive mucosal immune response | 🟢 Expert | Layered in Phase 2 when autoimmune component is dominant. |
The full dosing schedule, route, frequency, and reconstitution math arrive in Modules 3, 4, 7, and 8. This chapter's job is to make sure you understand why these four compounds, in this order, before any vial gets opened.
What's NOT happening yet
- You're not "healing the gut" by removing one food. Eliminating gluten or dairy may stop one zonulin trigger, but the tight junctions don't reseal on elimination alone. The epithelium needs repair signaling, not just the absence of insult.
- L-glutamine and bone broth are supporting actors, not the protocol. The practitioner corpus is clear that glutamine is the preferred fuel for enterocytes — it belongs in the stack. It does not, by itself, repair a damaged barrier or downregulate the immune cascade. It feeds cells that are already being told to repair.
- You're not chasing food sensitivities into infinity. Every new sensitivity that emerges is downstream of the same barrier failure. The list does not shrink by removing more foods; it shrinks by sealing the barrier so fewer antigens reach immune surveillance in the first place.
- You're not going to feel "healed" in two weeks. Enterocytes turn over every 3-5 days, but the immune memory of leaked antigens, the dysbiotic microbiome, and the cytokine inertia all run on longer timelines. Phase 1 reset is four weeks. Phase 2 rebuild is six. Sustained remission is the back half of the protocol, not the opening week.
- Probiotic supplementation alone won't fix this. Practitioner observation: probiotics dropped onto a damaged barrier with an inflamed lamina propria don't colonize stably. You repair the substrate first, then reseed.
Markers you'll be tracking
Module 6 covers the full lab panel. For now, know that the markers that matter are zonulin (serum or stool), calprotectin (stool, measures gut wall inflammation), LPS antibodies (serum, measures historical leakage), GI-MAP comprehensive stool panel (dysbiosis profile), and the downstream inflammatory markers — hs-CRP, food-sensitivity IgG panels, and whichever organ-specific autoimmune markers track your particular downstream expression (TPO for thyroid, ANA for systemic, etc.).
You're not treating leaky gut as a symptom. You're treating it as the upstream node of a network of disorders that look unrelated on the surface and share one mechanism underneath.
The corpus describes this loop with high consistency across practitioners. Track your markers. Adjust the stack to your data.